MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Secular trends and survival of Parkinson’s disease and other forms of parkinsonism in the United Kingdom

    S. Gandhi, K. Grosset, P. Iruthayaraj, R. Gravesande, L. Lee, C. Doyle, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

    Objective: We examined the UK incidence, prevalence and survival for eight parkinsonian disorders including Parkinson’s disease (PD) from 2003 to 2023, using primary and secondary…
  • 2025 International Congress

    Early-onset levodopa-responsive parkinsonism with cognitive impairment and head-bobbing dyskinesias associated with SYNJ1 and GBA variants of unknown significance

    S. Rodrigo, M. Rosenbaum, J. Fleisher (Chicago, USA)

    Objective: Describe the clinical and diagnostic findings of a patient with early-onset Parkinson’s Disease (EOPD) with homozygous variant of unknown significance (VUS) in the SYNJ1…
  • 2025 International Congress

    A Case of Mitochondrial Membraine Protein-Associated Neurodegeneration with Progressive Parkinsonism in a Young Male

    B. Akkineni, L. Teshome, E. Krause (Austin, USA)

    Objective: N/a Background: Less than a hundred cases of mitochondrial membrane protein-associated neurodegeneration (MPAN) have been reported thus far in literature. We present a case…
  • 2025 International Congress

    Diverse clinical phenotypes of ATP1A3 mutations-A case series of four patients

    S. Rath, V. Holla, P. Pal, N. Kamble, R. Yadav (BANGALORE, India)

    Objective: To study the clinical phenotype of all patients with ATP 1A3 mutation in the genetic study Background: ATP1A3 is associated with a broad spectrum…
  • 2025 International Congress

    Stepping backwards to move forward A case study on novel PT interventions for DLB

    K. Vasher, A. Boddy (Loma Linda, USA)

    Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…
  • 2025 International Congress

    4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies and CBD from PSP in post-mortem brain samples

    L. de Mena, M. Fernandez, J. Perez, C. Painous, A. Camara, A. Perez-Soriano, L. Molina-Porcel, E. Artikis, B. Caughey, Y. Compta (Barcelona, Spain)

    Objective: To investigate whether 4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies as well as CBD from PSP in post-mortem brain samples. Background: 4 repeat…
  • 2025 International Congress

    Neurogenic bladder and affective disorders in parkinsonism

    E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

    Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA. Background: In the group of patients with extrapyramidal pathology…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • 2025 International Congress

    Efficacy And Safety of Fecal Microbiota Transplant for Parkinson’s Disease: A Systematic Review And Meta-Analysis

    A. Koppanatham, A. Bin Gulzar, M. Ammar Arshad, E. de Farias, V. Suresh, M. Tariq, R. Vasireddy, T. Varkey (Lahore, Pakistan)

    Objective: To evaluate the efficacy and safety of Fecal Microbiota Transplantation (FMT) in patients with Parkinson’s disease (PD). Background: FMT is a novel therapy for…
  • 2025 International Congress

    Broad spectrum local field potential activities as a novel biomarker for adaptive deep brain stimulation

    CH. Tai, YC. Lin, WH. Hu, MT. Hsu, SH. Tseng (Hsinchu, Taiwan)

    Objective: This study aims to evaluate the wider frequency range (1-200 Hz) LFPs as the novel neural biomarkers for adaptive DBS. In parkinsonism rats, we…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley